ロード中...
N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells
BACKGROUND: Few patients with prostate cancer benefit from current immunotherapies. Therefore, we aimed to explore new strategies to change this paradigm. METHODS: Human tissues, cell lines and in vivo experiments were used to determine whether and how N-cadherin impacts the production of programmed...
保存先:
| 出版年: | J Immunother Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7949480/ https://ncbi.nlm.nih.gov/pubmed/33692219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002138 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|